Author response for "Association between Off-label use of Cardio-Kidney-Metabolic Therapies and risk of Cardiovascular Events in Type 1 Diabetes: A Real-World Evidence Study"

Publons reviews and discussion 2026

View at publisher

Authors: Ambarish Pandey, ENRICO REPETTO, Christopher Perkins, Peter Rossing, M. Luiza Caramori

DOI: 10.1111/dom.70597/v2/response1

Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Management and Research Diabetes Cardiovascular Risks and Lipoproteins